Ariel Isaacs

1.5k total citations · 1 hit paper
25 papers, 658 citations indexed

About

Ariel Isaacs is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Ariel Isaacs has authored 25 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Ariel Isaacs's work include SARS-CoV-2 and COVID-19 Research (6 papers), Virology and Viral Diseases (4 papers) and Viral Infections and Vectors (4 papers). Ariel Isaacs is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Virology and Viral Diseases (4 papers) and Viral Infections and Vectors (4 papers). Ariel Isaacs collaborates with scholars based in Australia, United Kingdom and United States. Ariel Isaacs's co-authors include J. Lindenmann, Daniel Watterson, Paul R. Young, Naphak Modhiran, Keith J. Chappell, Tanya M. Wildes, Christopher L. D. McMillan, Sascha A. Tuchman, Stacey T. M. Cheung and Mark A. Fiala and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Science Advances.

In The Last Decade

Ariel Isaacs

24 papers receiving 636 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pillars Article: Virus Interference. I. The Interferon. Proc R Soc Lond B Biol Sci. 1957. 147: 258-267.

2015 354 citations Ariel Isaacs, J. Lindenmann PubMed profile →

Peers

Countries citing papers authored by Ariel Isaacs

Since Specialization

Citations

This map shows the geographic impact of Ariel Isaacs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Isaacs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Isaacs more than expected).

Fields of papers citing papers by Ariel Isaacs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Isaacs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Isaacs. The network helps show where Ariel Isaacs may publish in the future.

Co-authorship network of co-authors of Ariel Isaacs

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Isaacs. A scholar is included among the top collaborators of Ariel Isaacs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Isaacs. Ariel Isaacs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Henipavirus in Northern Short-Tailed Shrew, Alabama, USA 2025 ·Emerging infectious diseases ·Rhys Parry, (unknown), Wendy R. Hood, Yang Zhao, (unknown), Andrei Seluanov, Vera Gorbunova, Naphak Modhiran, Daniel Watterson, Ariel Isaacs	0
2	Characterization of sleep disturbance in established rheumatoid arthritis patients: exploring the relationship with central nervous system pain regulation 2024 ·BMC Rheumatology ·(unknown), Lutfiyya N. Muhammad, Jing Song, Kathryn J. Reid, Daniela Grimaldi, Ariel Isaacs, Mary Carns, (unknown), Dorothy D. Dunlop, Rowland W. Chang, Phyllis C. Zee, Yvonne Lee	2
3	Structure and antigenicity of divergent Henipavirus fusion glycoproteins 2023 ·Nature Communications ·Ariel Isaacs, (unknown), (unknown), (unknown), Cassandra L. Pegg, Stacey T. M. Cheung, Benjamin Liang, Connor A. P. Scott, Michael J. Landsberg, Benjamin L. Schulz, Keith J. Chappell, Naphak Modhiran, Daniel Watterson	16
4	Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants 2022 ·Frontiers in Immunology ·Ariel Isaacs, Alberto A. Amarilla, Julio Aguado, Naphak Modhiran, Eduardo A. Albornoz, (unknown), Christopher L. D. McMillan, (unknown), Adi Idris, Aroon Supramaniam, Nigel A.J. McMillan, David A. Muller, Paul R. Young, Trent M. Woodruff, Ernst J. Wolvetang, Keith J. Chappell, Daniel Watterson	10
5	Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern 2022 ·Viruses ·(unknown), Kexin Yan, Thuy T. Le, (unknown), Alberto A. Amarilla, David A. Muller, Christopher L. D. McMillan, Naphak Modhiran, Daniel Watterson, (unknown), Julian D. J. Sng, Mary Lor, (unknown), Ariel Isaacs, Alexander A. Khromykh, Roy A. Hall, Andreas Suhrbier, Daniel J. Rawle, Jody Hobson‐Peters	9
6	Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine 2022 ·Frontiers in Immunology ·Jake S. O’Donnell, Ariel Isaacs, (unknown), (unknown), James Barnes, Patrick C. Reading, Paul R. Young, Daniel Watterson, Patrice Dubois, Nicolas Collin, Keith J. Chappell	8
7	A platform technology for generating subunit vaccines against diverse viral pathogens 2022 ·Frontiers in Immunology ·(unknown), Ariel Isaacs, Connor A. P. Scott, Naphak Modhiran, Christopher L. D. McMillan, Stacey T. M. Cheung, Jennifer Barr, Glenn A. Marsh, Nazia Thakur, Dalan Bailey, (unknown), Hayes K. H. Luk, Kin‐Hang Kok, Susanna K. P. Lau, Patrick C. Y. Woo, Wakako Furuyama, Andrea Marzi, Paul R. Young, Keith J. Chappell, Daniel Watterson	13
8	Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates 2021 ·Viruses ·Ariel Isaacs, Stacey T. M. Cheung, Nazia Thakur, (unknown), (unknown), Naphak Modhiran, Dalan Bailey, Simon P. Graham, Paul R. Young, Keith J. Chappell, Daniel Watterson	10
9	Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine 2021 ·Science Advances ·Christopher L. D. McMillan, (unknown), Adi Idris, Aroon Supramaniam, Naphak Modhiran, Alberto A. Amarilla, Ariel Isaacs, Stacey T. M. Cheung, Benjamin Liang, Helle Bielefeldt‐Ohmann, Armira Azuar, Dhruba Acharya, Gabrielle Kelly, Germain J. P. Fernando, Michael J. Landsberg, Alexander A. Khromykh, Daniel Watterson, Paul R. Young, Nigel A.J. McMillan, David A. Muller	32
10	Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell–cell fusion 2020 ·Journal of General Virology ·Nazia Thakur, Carina Conceicao, Ariel Isaacs, Stacey Human, Naphak Modhiran, Rebecca McLean, Miriam Pedrera, Tiong Kit Tan, Pramila Rijal, Alain Townsend, Geraldine Taylor, Paul R. Young, Daniel Watterson, Keith J. Chappell, Simon P. Graham, Dalan Bailey	12
11	Bovine Herpesvirus-4-Vectored Delivery of Nipah Virus Glycoproteins Enhances T Cell Immunogenicity in Pigs 2020 ·Vaccines ·Miriam Pedrera, Francesca Macchi, Rebecca McLean, Valentina Franceschi, Nazia Thakur, (unknown), (unknown), Shawn Todd, Elma Tchilian, Jean-Christophe Audonnet, Keith J. Chappell, Ariel Isaacs, Daniel Watterson, Paul R. Young, Glenn A. Marsh, Dalan Bailey, Simon P. Graham, Gaetano Donofrío	29
12	A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2 2020 ·Molecules ·(unknown), (unknown), Naveed A. Nadvi, Karishma Patel, (unknown), Hui Zhang, Chandrika Deshpande, Jason K. K. Low, (unknown), Yiqian Chen, Christopher L. D. McMillan, Ariel Isaacs, Brenna Osborne, (unknown), Geoffrey W. McCaughan, Joel P. Mackay, W. Bret Church, Mark D. Gorrell	21
13	Rapid Response Subunit Vaccine Design in the Absence of Structural Information 2020 ·Frontiers in Immunology ·Danushka K. Wijesundara, Michael S. Avumegah, (unknown), Naphak Modhiran, Ariel Isaacs, Paul R. Young, Daniel Watterson, Keith J. Chappell	9
14	A comparison of three different approaches to defining frailty in older patients with multiple myeloma 2019 ·Journal of Geriatric Oncology ·Ariel Isaacs, Mark A. Fiala, Sascha A. Tuchman, Tanya M. Wildes	23
15	Pillars Article: Virus Interference. I. The Interferon. Proc R Soc Lond B Biol Sci. 1957. 147: 258-267 2015 ·The Journal of Immunology ·Ariel Isaacs, J. Lindenmann	3
16	Pillars Article: Virus Interference. II. Some Properties of Interferon. Proc R Soc Lond B Biol Sci. 1957. 147: 268–273 2015 ·The Journal of Immunology ·Ariel Isaacs, J. Lindenmann, Raymond C. Valentine	2
17	Virus Interference: I. The Interferon 1988 ·CA A Cancer Journal for Clinicians ·Ariel Isaacs, J. Lindenmann	20
18	Antiviral Action of Interferon 1962 ·BMJ ·Ariel Isaacs	32
19	Versuche über Virus-Interferenz 1957 ·Pathobiology ·J. Lindenmann, Ariel Isaacs	4
20	[Research on viral interference]. 1957 ·PubMed ·J. Lindenmann, Ariel Isaacs	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact